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ABSTRACT 
 The present study was undertaken to evaluate the 
anxiolytic and anti epileptic activity of   ethonolic extract of 
Flemingia macrophylla by using different extract 
concentrations in rodents. Anxiolytic activity of FME was 
estimated by using Elevated plus maze test and light-dark 
model along with Mono Amino Oxidase enzyme levels in 
mice and the anticonvulsant activity of FME was estimated 
in rats by using MES , PTZ methods and those showing 
response were divided into four groups of six animals each. 
Group-I (Normal), Group-II (Diazepam 2mg/ Kg , p.o) , 
Group-III (FME 20mg/Kg in mice, 100mg/Kg in rats, p.o), 
Group-IV(FME 50mg/Kg in mice, 200mg/Kg , p.o). 
Animals treated with FME had shown a significant increase 
in enzyme levels and significant decrease in anxiety and 
onset of convulsions when compared with the diazepam 
treated animals.  The ethanolic extract of Flemingia 
macrophylla afforded significant protection against anxiety 
and epilepsy. The activity may be due to the presense of 
flavonoids& glycosides. 
KEY WORDS: Anti anxiety, Anti epileptic, Flemingia 
macrophylla , Diazepam, Pentylene tetrazole. 
 
INTRODUCTION 
Anxiety is a universal feeling state and is part of the fabric 
of everyday life.  Feelings of anxiety and fear often are 
unpleasant emotions commonly caused by the perception of 
actual or potential (anticipatory) danger that threatens the 
security of the individual[1]. Epilepsy is a physical 
condition that occurs when there is a sudden, brief change 
in how the brain works. When brain cells are not working 
properly, a person's consciousness, movement, or actions 
may be altered for a short time. These physical changes are 
called epileptic seizures. Epilepsy is therefore sometimes 
called a seizure disorder[1]. 
A major revolution in clinical neuropharmacology and 
psychopharmacology was herald during the past years. The 
natural compounds have played a major role in 
neurological disorders. A number of herbal drugs 
traditionally employed in the Indian system of medicine 
Ayurveda.  Herbal medicines are being used by about 80% 
of the world population primarily in the developing 
countries for primary health care[2]. 
Flemingia macrophylla belongs to the family Fabaceae.  In 
some areas, such as Ghana,              Flemingia macrophylla 
remains green throughout the year and retains most of its 
leaf during the dry season, making it suitable as a dry-
season browse species. In Indonesia and Malaysia, the 
leaves are used medicinally. In China, a decoction is used 
to bathe sores and swellings, while in Taiwan it is an 
antipyretic for treating postpartum fever and is used to treat 
paralysis and pain in the joints. Some the plants of this 
were proved as antibacterial agent, anthelmintic agent. As a 
folk medicine it is used in ulcers, vertigo, vitiligo, hysteria, 
vermifuge. Roots are used for the external application for 
ulcers & swellings. Various plant  parts used in spleen 
complaints, smallpox, prolapsusani, cholera, dysentery and 
in blindness. The main aim of this study is to estimate the 
antianxiety &anticonvulsant activity of aerial parts of the 
plant based On the study of neuroprotective activity of 
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MATERIALS & METHODS 
Plant material 
Flemingia macrophylla aerial parts were collected from the 
Talakona forest in Tirupathi , Andhrapradesh, India and 
authentified by the normal pharmacognistic procedures by                 
Dr. K. Madhavchetty, a senior botanist in Sri venkateswara 
University(SVU), Tirupathi, India. 
Preparation Of Extraction 
The plant parts were dried under room temperature (1000g) 
were defatted with petroleumetherand extracted with 95% 
ethanol by continuous hot perculation method using 
Soxhlet apparatus. The extract was made free from the 
solvent by evaporation. The extact was tested for 
phytochemical screening. 
Drugs and chemicals 
Diazepam (Ranbaxy Laboratories Ltd,  India), Pentylene 
tetrazole (Sigma-Aldrich, St.Louis, MO63103, USA) were 
used for the study. All the solvents used for the extraction 
process are of Laboratory grade and they are purchased 
from local firms. 
Animals 
Swiss albino mice of either sex    (25-30 g) were 
maintained for 7 days in the animal house under standard 
conditions, temperature (24 ± 10°C), relative humidity (45-
55%) and 12:12 light: dark cycle. The animals were fed 
with standard rat pellet and water ad libitum. The animals 
were allowed to acclimatize to laboratory conditions 48hr 
before the start of the experiment. 
Experimental model 
The animals were divided into 4 groups (n=6), Group-I 
(Normal) treated with saline (0.9%), Group-II (Standard) 
treated with the Diazepam (2mg/Kg), Group-III, IV (test 
animals) treated with extract (20mg/Kg, 50 mg/Kg). The 
experimental protocol was approved by the     Institutional 
Animal Ethical Committee (IAEC) of the SRM University, 
Kattankulathur,      Tamil Nadu, India.  All the experiments 
were conducted according to the guidelines of Committee 
for the Purpose of Control and Supervision on Experiments 




The Elevated plus-maze test is described elsewhere. The 
apparatus comprises of two openarms (35 cm ×5 cm) and 
two closed arms (30 cm × 5 cm ×15cm) that extend from a 
common central platform (5 cm ×5 cm). The floor and 
walls of the closed is painted black. The entire maze is 
elevated to height of 50 cm above the floor level. Mice of 
18-22g weight were housed in pair for 10 days prior to 
testing in the apparatus. During this time the mice are 
handled by the investigator on alternate days to reduce 
stress. A group consisting of 6 mice was used for each dose 
level. One hour after oral administration of the vehicle or 
standard or extract, each mouse was placed in the center of 
the maze facing towards one of the open arm. During a five 
minutes session, the following parameters were noted; 
Number of entries into open arm, Number of entries into 
closed arm, Time spent in the open arm, and Time spent in 




   
 Light dark box is a rectangular box of 46 x 27 x 30 cm (l x 
b x h), which is divided in to 2 compartment 1/3 rd is for 
the dark compartment and 2/3 rd served as light 
compartment. Extract/vehicle or standard drugs will be 
administered through per oral route. Sixty min after oral 
administration the mouse were placed individually on the 
light compartment and observe for a period of 5 min. 
Number of  locomotion, time spent in light and dark zones 
and number entries in light, dark zone were observed 
during this observation period. 
Mono Amine Oxidase Assay (MAO)
[10] 
                     Mouse brain mitochondrial fraction will be 
prepared by cutting the brain sample in to small pieces and 
rinsed in 0.25m sucrose 0.1 m tris 0.02m EDTA (pH7.4) to 
remove blood. The pieces will be homogenized for 45 sec 
in a potter-elvehjem homogenizer with 400 ml of the same 
medium. Tile homogenate will be centrifuged at 800xg for 
10min and the pellets will be discarded. The supernatant 
will be centrifuged at 12,000xg for 20 min in the same 
medium. The precipitate will be washed twice more with 
100ml of sucrose tris EDTA and resuspended in 50ml of 
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the medium. The protein concentration will be adjusted to 1 
mg/ml.  MAO activity was assessed spectrometrically.  
                         The assay mixture contain 4mm of 
serotonin as specific substrates for MAO-A, 250µl solution 
of the mitochondrial fraction and 100mm sodium 
phosphate buffer (pH7.4) up to the final volume of 1ml, the 
reaction will be be allowed to proceed at 37 º c for 20 
minutes and stopped by adding 1M HCl (200µl), the 
reaction product will be extracted with 5ml of butyl acetate, 
the organic phase was measured at wavelength of 280 nm 
in a spectrometer. Blank samples will be prepared by 
adding 1m HCl (200µl) prior to the reaction and worked 
subsequently in the same manner. 
Assesment Of Antiepileptic activity 
Pentylenetetrazole induced convulsion
[11] 
Male swiss albino mice weighing between 18-25g were 
divided into four groups, each group comprising of six 
animals, One hour after vehicle or standard or extract 
treatment, PTZ (pentylenetetrazole 80 mg/kg) was 
administered by intraperitoneally(i.p) to all the animals. 
Each animal was placed in to individual plastic cage and 
observed initially for 30min and later up to 24 hrs. The 
following parameters were recorded during test session of 
initial 30min and up to 24 hrs;  Onset of clonic convulsions, 
Status of animal after 24 hrs. 
Maximal electroshock test (MES)
[11] 
               An alternating current stimulus of 50 Hz and 150 
mA through bicorneal electrodes will be delivered for 0.2 s 
to the experimental animals. A drop of 0.9% saline solution 
should be poured into each eye prior to placing the 
electrodes. Duration of clonic convulsion and percentage of 
mortality will be recorded. 
RESULTS 
Phytochemical Screening 
It was found that the alcoholic extract of Flemingia 
macrophylla contains flavonoids, glycosides. 
 
 
Assesment of antianxiety activity 
 Table1: Elevated plusmaze test 
 
Group                Drug                 
                          treated 




Open arm      Closed arm Open arm        Closedarm 
I                       Normal          6±0.04**       10.24±0.4**   44.2±3.17       191.31±1.3*           53±3.3** 
 
 
II                   Diazepam      10.67±0.3         57.36±0.42    26.91±2.03      245.37±8.67          19±2.4 
                      (2mg/Kg) 
 
 
III                  FME              9.3±0.24**    10.01±0.03**  28.51±3.81*   195.77±1.06*        23.7±0.6* 
                    (20mg/Kg) 
 
IV                  FME               11.6±0.46*      9.11±0.42*     29±1.8**        176.3±0.6**        25.11±1.12** 
                  (50mg/Kg) 
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 Table 2: Light-Dark Model 
Group       Drug treated                                Number of entries  
in light(sec)                            Timespent in lightbox(sec)   
Total 
locomotion(cou
nts/min)     
 I                  Normal                7.3±0.47**                                 20.4±0.9**                           140.5±1.9**      
 
II                  Diazepam            14.6±0.8                                    102.2±1.45                              90.7±0.9                  
                    (2mg/Kg)   
 
III                  FME                  10.6±0.7**                                107.7±0.6*                            112.6±2.6**      
                   (20mg/Kg) 
 
IV                  FME                 12.1 ±0.6*                                  100±0.43*                           100.48±1.5**   
                   (50mg/Kg) 
   
 **P<0.01.*P<0.05 (Dunnet test, which compares test groups and standard drug group with control 
 
 group);number of animals per group=6 
 
 
Table3: Effect of FME on MAO levels 
  
              Drug treated                                            MAO levels 
 
Control                                                               19.12±0.91** 
Diazepam(2mg/Kg)                                            23.69±1.78 
FME(20mg/kg)                                                   24.21±  0.9** 
FME(50mg/Kg)                                                  25.02±1.1 
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Assesment of antiepileptic activity 
Table4 : Effect Of FME in MES induced convulsions 
 
Group                Drug                 
                          treated 
                        Time duration(sec) 
Flexion            Extension       Convulsion        Stupor         Recovery/Death 
 
I                       Normal       53±1.27**       70±2.90*         90.3±0.73**   101.11±3.41**    Recovery 
 
 
II                   Diazepam     24.6±0.18       23±1.10             19.1±0.09        9.9±0.18             Recovery       
                      (2mg/Kg) 
 
III                  FME            28.3±0.19**   19.21±1.6**      10.2±0.76**     5.5±0.19**         Recovery 
                     (20mg/Kg) 
 
IV                  FME            27.3±0.2*        17.4±1.2*         9.1±0.29**       3.4±0.2**            Recovery 
                   (50mg/Kg) 
 
**P<0.01.*P<0.05 (Dunnet test, which compares test grouos and standard drug group with control group);number of animals per 
group=6 
 
Table5: Effect Of FME on PTZ induced seizures 

























**P<0.01.*P<0.05 (Dunnet test, which compares test grouos and standard drug group with control group);number of animals per 
group=6 
DISCUSSION 
FME treated animals and Diazepam treated animals had 
shown significant activity in elevated plus maze test 
particularly in number of entries, time spent Table:1. The 
FMEextract treated animals had shown significant activity 
than standard (Diazepam) treated animals. In light and dark 
model also animals had shown more significant activity 
like standard animals by preferring the light region than 
dark region Table:2 and significant increase in enzyme 
levelsTable:3 Evaluation of antiepileptic activity revealed 
that there was a significant activity was shown by the 
animals than the standard. In MES induced convulsion 
model there was a significant decrease in extension, 
convulsion and stupor stage when compared with the 
Diazepam treated animals Table:4. In PTZ the onset of 
convulsion was decreased in FME treated animals better 
than the Diazepam treated animals which were  recovered 








By this study we can conclusively state that Flemingia 
macrophylla  has definite beneficial role as an anxiolytic & 
anticonvulsant. It can serve as a good adjuvant in the 
present armamentarium of anticonvulsant drugs and 
support its traditional usage in the treatment of both in 
anxiety and convulsions. Further studies is required for the 
detailed studies in isolation of the compounds and 
pharmacological investigations of the other plant 
constitiuents, which have many pharmacological activity 
reported traditionally and its exact mechanism of action. 
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